NEW YORK (GenomeWeb News) – Startup drug developer Constellation Pharmaceuticals will use BioTrove’s screening and analysis system to develop new therapeutics using an epigenetics-focused approach, BioTrove said today.
 
Constellation will use BioTrove’s RapidFire mass spectrometry system in its screening efforts aimed at developing drugs that can manipulate histone proteins to alter gene expression.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.